Aurobindo Pharma
AUROPHARMA.NS
S$16.78
Share price
-0.45%
Change (1 day)
-20.71%
Change (1 year)
Categories
Aurobindo Pharma (AUROPHARMA.NS) - Total debt
Total debt on the balance sheet as of March 2025 : S$1.23 Billion
According to Aurobindo Pharma 's latest financial reports the company's total debt is S$1.23 Billion. A company’s total debt is the sum of all current and non-current debts.
Aurobindo Pharma - Total debt on balance sheet (from 2012 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-03-31 | S$1.07 B | 25.59% |
| 2023-03-31 | S$0.85 B | 46.27% |
| 2022-03-31 | S$0.58 B | -40.37% |
| 2021-03-31 | S$0.98 B | -17.52% |
| 2020-03-31 | S$1.18 B | -12.48% |
| 2019-03-31 | S$1.35 B | 41.45% |
| 2018-03-31 | S$0.96 B | 32.62% |
| 2017-03-31 | S$0.72 B | -29.4% |
| 2016-03-31 | S$1.02 B | 5.89% |
| 2015-03-31 | S$0.96 B | 22.54% |
| 2014-03-31 | S$0.79 B | 0.65% |
| 2013-03-31 | S$0.78 B | 2.66% |
| 2012-03-31 | S$0.76 B | 11.8% |
| 2011-03-31 | S$0.68 B | 1.39% |
| 2010-03-31 | S$0.67 B | -4.2% |
| 2009-03-31 | S$0.70 B | 6.71% |
| 2008-03-31 | S$0.66 B | -9.86% |
| 2007-03-31 | S$0.73 B | 46.37% |
| 2006-03-31 | S$0.50 B | 26.93% |
| 2005-03-31 | S$0.39 B | 24.37% |
| 2004-03-31 | S$0.31 B |